Carolina Cabral, MD
Cardiovascular Disease · Morristown, NJNPI 1013183623
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,930 of the $8,661 with a category attached, or 80.0%. Alnylam Pharmaceuticals Inc. accounts for 95.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $8,565 and has fallen 99.4% since, to $52 in 2023.
Across 44 payments — averaging $196.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$8K
- Novartis$130
- Johnson & Johnson$52
- Gilead$50
- Abiomed$30
- Abbott$19
- plus $76 from 5 others
What the payments were for
- Consulting fees$6,93080%
- Travel & lodging$1,08212%
- Food & beverage$6297%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 17 | $8,304 |
| Novartis | 15 | $130 |
| Johnson & Johnson | 2 | $52 |
| Gilead | 3 | $50 |
| Abiomed | 1 | $30 |
| Abbott | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Boehringer Ingelheim | 1 | $15 |
| Akcea Therapeutics, Inc. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONPATTRO$7,969
How this compares
$8,661 in reported general payments places this provider in the 75th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Morristown
- Gennaro GiustinoMorristown$135K
- Konstantinos KoulogiannisMorristown$123K
- Linda GillamMorristown$61K
- Robert KippermanMorristown$48K
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.